18/11/2019 : THERADIAG announces CE marking approval for its new i-Track10 automated analyzer for biotherapy monitoring

TĂ©lĂ©charger/Download Croissy-Beaubourg, November 18, 2019, 8:00 am CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has obtained the CE marking for its i-Track10…

Continue Reading 18/11/2019 : THERADIAG announces CE marking approval for its new i-Track10 automated analyzer for biotherapy monitoring